Cargando…

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression

SIMPLE SUMMARY: Nucleolin (NCL) regulates tumour growth and angiogenesis, and its inhibition normalizes tumour vessels and impairs pancreatic ductal adenocarcinoma (PDAC) growth. Since tumour vessel normalization promotes immunostimulatory reprogramming, we investigated the effects of a selective in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponzo, Matteo, Debesset, Anais, Cossutta, Mélissande, Chalabi-Dchar, Mounira, Houppe, Claire, Pilon, Caroline, Nicolas-Boluda, Alba, Meunier, Sylvain, Raineri, Fabio, Thiolat, Allan, Nicolle, Rémy, Maione, Federica, Brundu, Serena, Cojocaru, Carina Florina, Bouvet, Philippe, Bousquet, Corinne, Gazeau, Florence, Tournigand, Christophe, Courty, José, Giraudo, Enrico, Cohen, José L., Cascone, Ilaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454580/ https://www.ncbi.nlm.nih.gov/pubmed/36077801 http://dx.doi.org/10.3390/cancers14174265

Ejemplares similares

Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
por: Ponzo, Matteo, et al.
Publicado: (2022)

Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma
por: Raineri, Fabio, et al.
Publicado: (2021)

Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation
por: Chalabi-Dchar, Mounira, et al.
Publicado: (2021)

Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy
por: Diamantopoulou, Zoi, et al.
Publicado: (2017)

Integrated analysis of mRNA and miRNA expression in HeLa cells expressing low levels of Nucleolin
por: Kumar, Sanjeev, et al.
Publicado: (2017)

The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options
por: Ferrara, Benedetta, et al.
Publicado: (2021)

The Nucleolin Antagonist N6L Inhibits LINE1 Retrotransposon Activity in Non-Small Cell Lung Carcinoma Cells
por: Ramos, Kenneth S., et al.
Publicado: (2020)

Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L
por: Birmpas, Charalampos, et al.
Publicado: (2012)

Expression of Nucleolin Affects Microtubule Dynamics
por: Gaume, Xavier, et al.
Publicado: (2016)

The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis
por: Birmpas, Charalampos, et al.
Publicado: (2012)

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment
por: Nicolas-Boluda, Alba, et al.
Publicado: (2021)

In vivo Study of the Histone Chaperone Activity of Nucleolin by FRAP
por: Gaume, Xavier, et al.
Publicado: (2011)

Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin
por: Koutsioumpa, Marina, et al.
Publicado: (2012)

A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate
por: Chalabi-Dchar, Mounira, et al.
Publicado: (2021)

Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin
por: Destouches, Damien, et al.
Publicado: (2008)

Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication
por: Ugrinova, Iva, et al.
Publicado: (2007)

Interaction of nucleolin with ribosomal RNA genes and its role in RNA polymerase I transcription
por: Cong, Rong, et al.
Publicado: (2012)

AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation
por: Iturriaga-Goyon, Emilio, et al.
Publicado: (2021)

Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice
por: El Khoury, Diala, et al.
Publicado: (2010)

Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma
por: Dzhumashev, Dzhangar, et al.
Publicado: (2022)

Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
por: Nguyen Van Long, Flora, et al.
Publicado: (2018)

TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation
por: Moatti, Audrey, et al.
Publicado: (2022)

Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis
por: Carvalho, Laura Sofia, et al.
Publicado: (2021)

Overexpression of Nucleolin and Associated Genes in Prostate Cancer
por: Firlej, Virginie, et al.
Publicado: (2022)

Insights into the binding mode of AS1411 aptamer to nucleolin
por: Bie, Lihua, et al.
Publicado: (2022)

Anti-nucleolin aptamer AS1411: an advancing therapeutic
por: Van den Avont, Alexander, et al.
Publicado: (2023)

Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients
por: Marcel, Virginie, et al.
Publicado: (2017)

Cationic Polyethyleneimine (PEI)–Gold Nanocomposites Modulate Macrophage Activation and Reprogram Mouse Breast Triple-Negative MET-1 Tumor Immunological Microenvironment
por: Mulens-Arias, Vladimir, et al.
Publicado: (2022)

Roles of nucleolin: Focus on cancer and anti-cancer therapy
por: Chen, Zhuo, et al.
Publicado: (2016)

A novel nucleolin-binding peptide for Cancer Theranostics
por: Kim, Jae-Hyun, et al.
Publicado: (2020)

A novel role for nucleolin in splice site selection
por: Shefer, Kinneret, et al.
Publicado: (2022)

Nucleolin: a cell portal for viruses, bacteria, and toxins
por: Tonello, Fiorella, et al.
Publicado: (2022)

Nucleolin expression has prognostic value in neuroblastoma patients
por: Cangelosi, Davide, et al.
Publicado: (2022)

Identification of Nucleolin as New ErbB Receptors- Interacting Protein
por: Di Segni, Ayelet, et al.
Publicado: (2008)

Nucleolin Inhibits G4 Oligonucleotide Unwinding by Werner Helicase
por: Indig, Fred E., et al.
Publicado: (2012)

Structure-Function Analysis of Nucleolin and ErbB Receptors Interactions
por: Farin, Keren, et al.
Publicado: (2009)

Stat1 Nuclear Translocation by Nucleolin upon Monocyte Differentiation
por: Jerke, Uwe, et al.
Publicado: (2009)

MicroRNA Profiling of Transgenic Mice with Myocardial Overexpression of Nucleolin
por: Lyu, Qing-Lan, et al.
Publicado: (2018)

Targeting nucleolin to obstruct vasculature feeding with an intelligent DNA nanorobot
por: Li, Hua, et al.
Publicado: (2018)

Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
por: Lin, Qianhan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9b0ufa13ianni2ll3j605r54da